Effect of a Shoulder Movement Intervention on Joint Mobility, Pain, and Disability in People With Diabetes: A Randomized Controlled Trial

肩部运动干预对糖尿病患者关节活动度、疼痛和功能障碍的影响:一项随机对照试验

阅读:1

Abstract

BACKGROUND: People with diabetes are at high risk for shoulder pain, limited joint mobility, and adhesive capsulitis. OBJECTIVE: The objective of this study was to evaluate the effects of a shoulder movement intervention (ShoMo) compared to a wellness intervention on the primary outcomes of active shoulder flexion and reported Shoulder Pain and Disability Index (SPADI) measured after intervention and 9 months later. DESIGN: The design was a prospective, randomized, controlled clinical trial. SETTING: The setting was a research center at an academic medical center. PARTICIPANTS: Fifty-two participants with type 2 diabetes and shoulder pain or limited motion were randomized to a group receiving ShoMo (N = 27; mean age = 59.3; SD = 7.0) or a group receiving wellness activities (N = 25; mean age = 57.9; SD = 7.7). INTERVENTION: The ShoMo group received instruction in a progressive, active shoulder movement program. The wellness group received instruction in diabetes management. MEASUREMENTS: Measurements were made at baseline, after 3 months of intervention, and at 6, 9, and 12 months after baseline. RESULTS: After intervention, the ShoMo group had a 7.2-degree increase in active shoulder flexion compared with the wellness group (95% CI = 0.9-13.5°), but there was no difference at subsequent follow-ups. The ShoMo group showed a 12.7-point improvement in the SPADI score compared to the wellness group after intervention (95% CI = 1.1-24.3), which remained better than the wellness group 9 months later. LIMITATIONS: The number of participants and duration of follow-up were inadequate to determine if intervention can help to prevent future severe shoulder problems. CONCLUSIONS: A progressive shoulder movement program can have meaningful effects on active motion and symptoms in people with type 2 diabetes and mild-to-moderate shoulder symptoms, with symptom improvement lasting at least 9 months.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。